Birchview Capital’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Sell |
210,000
-5
| -0% | -$57 | 2.37% | 10 |
|
|
2025
Q1 | $1.4M | Buy |
210,005
+5
| +0% | +$33 | 1.21% | 21 |
|
|
2024
Q4 | $2.32M | Hold |
210,000
| – | – | 1.88% | 16 |
|
|
2024
Q3 | $2.58M | Hold |
210,000
| – | – | 2.23% | 14 |
|
|
2024
Q2 | $2.84M | Hold |
210,000
| – | – | 2.62% | 11 |
|
|
2024
Q1 | $2.84M | Hold |
210,000
| – | – | 2.31% | 10 |
|
|
2023
Q4 | $1.1M | Buy |
210,000
+125,000
| +147% | +$658K | 0.86% | 24 |
|
|
2023
Q3 | $335K | Hold |
85,000
| – | – | 0.28% | 39 |
|
|
2023
Q2 | $904K | Buy |
85,000
+70,000
| +467% | +$744K | 0.68% | 26 |
|
|
2023
Q1 | $125K | Hold |
15,000
| – | – | 0.1% | 50 |
|
|
2022
Q4 | $138K | Hold |
15,000
| – | – | 0.1% | 51 |
|
|
2022
Q3 | $193K | Hold |
15,000
| – | – | 0.14% | 51 |
|
|
2022
Q2 | $198K | Hold |
15,000
| – | – | 0.14% | 51 |
|
|
2022
Q1 | $316K | Hold |
15,000
| – | – | 0.23% | 50 |
|
|
2021
Q4 | $360K | Hold |
15,000
| – | – | 0.23% | 51 |
|
|
2021
Q3 | $382K | Hold |
15,000
| – | – | 0.26% | 48 |
|
|
2021
Q2 | $505K | Hold |
15,000
| – | – | 0.3% | 44 |
|
|
2021
Q1 | $583K | Sell |
15,000
-5,000
| -25% | -$194K | 0.35% | 41 |
|
|
2020
Q4 | $1.24M | Hold |
20,000
| – | – | 0.71% | 24 |
|
|
2020
Q3 | $670K | Hold |
20,000
| – | – | 0.45% | 28 |
|
|
2020
Q2 | $477K | Hold |
20,000
| – | – | 0.29% | 37 |
|
|
2020
Q1 | $458K | Buy |
+20,000
| New | +$458K | 0.41% | 30 |
|